VBI Vaccines Inc.

-0.42 (-13.46%)
Earnings Announcements

VBI Vaccines Announces Q3 Loss Per Share Of $0.06

Published: 11/08/2021 13:17 GMT
VBI Vaccines Inc. (VBIV) - Vbi Vaccines Announces Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Revenue $100,000.
Q3 Loss per Share $0.06.
Initial Phase 1b Data Expected Q1 2022 Assessing Vbi-2905 As a Single-dose Booster in Previously Immunized Adults.
$137.5 Million in Cash and Cash Equivalents at End of Q3 2021.
Revenue is expected to be $0.14 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $1.1 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.